Stocks and Investing Stocks and Investing
Thu, August 6, 2020
Wed, August 5, 2020

Matthew Mishan Maintained (AVNS) at Buy with Decreased Target to $43 on, Aug 5th, 2020


Published on 2024-10-27 11:37:21 - WOPRAI, Matthew Mishan
  Print publication without navigation


Matthew Mishan of Keybanc, Maintained "Avanos Medical, Inc." (AVNS) at Buy with Decreased Target from $45 to $43 on, Aug 5th, 2020.

Matthew has made no other calls on AVNS in the last 4 months.



There are 2 other peers that have a rating on AVNS. Out of the 2 peers that are also analyzing AVNS, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Kristen Stewart of "Barclays" Upgraded from Sell to Hold on, Monday, April 13th, 2020


This is the rating of the analyst that currently disagrees with Matthew


  • David Lewis of "Morgan Stanley" Maintained at Sell with Increased Target to $31 on, Thursday, May 7th, 2020
Contributing Sources